Status:

COMPLETED

Does Lowering Eye Pressure Affect the Results Obtained From Objective Visual Field Testing?

Lead Sponsor:

Wills Eye

Collaborating Sponsors:

Pfizer

Conditions:

Glaucoma

Eligibility:

All Genders

Brief Summary

A study to determine whether a patient's range of vision test results improve after their eye pressure is lowered by 30% or more by testing on a new machine called the Accumap and how to learn how muc...

Detailed Description

Accumap testing will be performed before and two to three hours after treatment is initiated to lower IOP. In eye that have bilateral treatment, one eye will be assigned randomly to the study. The mea...

Eligibility Criteria

Inclusion

  • Consecutive patients seen that have their intraocular pressures lowered by at least 30% over the course of two hours.

Exclusion

  • Recent (within 6 weeks) intraocular surgery
  • Visual acuity worse than 20/40
  • Pathology unrelated to glaucoma (retinal disease, stroke, brain tumor, etc) associated with visual field defect
  • Prior corneal transplant, corneal edema, or corneal diseases such as keratoconus or dense scarring

Key Trial Info

Start Date :

October 1 2004

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2007

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT00799994

Start Date

October 1 2004

End Date

January 1 2007

Last Update

November 22 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wills Eye

Philadelphia, Pennsylvania, United States, 19107